![Michael Graves](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Graves
Directeur Général chez
EAGLE PHARMACEUTICALS, INC.
Profil
Mr. Michael Graves is a Chairman & Chief Executive Officer at Eagle Pharmaceuticals, Inc. and an Executive Chairman at Nanocopoeia, Inc. He is on the Board of Directors at RiboCor, Inc. Mr. Graves was previously employed as a President & Chief Executive Officer by Paddock Laboratories, Inc., a President-Generic Products Division by Par Pharmaceutical Cos., Inc., and a President-Generic Products Division by Par Pharmaceutical, Inc. He received his undergraduate degree from State University of New York at Buffalo.
Postes actifs de Michael Graves
| Sociétés | Poste | Début |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Directeur Général | 27/11/2023 |
Ribocor, Inc.
 Ribocor, Inc. Pharmaceuticals: MajorHealth Technology Developes nutritional, medical and pharmaceutical products | Directeur/Membre du Conseil | 01/01/2012 |
Anciens postes connus de Michael Graves
| Sociétés | Poste | Fin |
|---|---|---|
Paddock Laboratories, Inc.
 Paddock Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bioequivalent generic pharmaceuticals | Directeur Général | 01/07/2011 |
| PAR PHARMACEUTICAL COMPANIES, INC. | Corporate Officer/Principal | 15/11/2006 |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Corporate Officer/Principal | 01/01/2006 |
Nanocopoeia, Inc.
 Nanocopoeia, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical formulation, medical device coating and specialty biotechnology research | Président | - |
Formation de Michael Graves
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States | Health Technology |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Health Technology |
Paddock Laboratories, Inc.
Paddock Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bioequivalent generic pharmaceuticals | Health Technology |
Ribocor, Inc.
Ribocor, Inc. Pharmaceuticals: MajorHealth Technology Developes nutritional, medical and pharmaceutical products | Health Technology |
Nanocopoeia, Inc.
Nanocopoeia, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical formulation, medical device coating and specialty biotechnology research | Commercial Services |
